⌘K

Login Start Free

Home/Filings/4/0001645113-21-000070

4//SEC Filing

LEUNG GABRIEL 4

Accession 0001645113-21-000070

CIK 0001645113other

View on SEC.gov Company Profile

Filed

Jun 7, 8:00 PM ET

Accepted

Jun 8, 4:49 PM ET

Size

8.2 KB

Accession

0001645113-21-000070

Insider Transaction Report

Form 4

Period: 2021-06-07

NovoCure LtdNVCR

Director

Transactions

Exercise/Conversion
Options to Buy Ordinary Shares
2021-06-07−1,000→ 4,345 total
Exercise: $31.45Exp: 2028-05-30→ Ordinary Shares (1,000 underlying)
Exercise/Conversion
Ordinary Shares
2021-06-07$31.45/sh+1,000$31,450→ 73,045 total
Sale
Ordinary Shares
2021-06-07$204.55/sh−1,000$204,550→ 72,045 total

Footnotes (2)

[F1]Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Leung.
[F2]Fully vested as of the date hereof.

Documents

1 file

4
wf-form4_162318536093579.xmlPrimary
FORM 4

Issuer

NovoCure Ltd

CIK 0001645113

Entity typeother

Related Parties

1

filerCIK 0001236183

Filing Metadata

Form type: 4
Filed: Jun 7, 8:00 PM ET
Accepted: Jun 8, 4:49 PM ET
Size: 8.2 KB

View on SEC.gov